Masthead-Image-Right-min

Mitigating the Financial Consequences of COVID-19

Is it time to automate your RCM? Learn more about the advantages and how to evaluate if it would benefit your organization.

Continue Reading...

Navigating Reimbursement for Liquid Biopsy Cancer Testing

Thirty-eight percent of private payers now cover some type of ctDNA-based panel testing. Is your lab aware of evolving payment policies?

Continue Reading...

The Right Automation is More Important Than Ever

There are more technology-driven opportunities to ‘fix’ your RCM than ever before, why aren’t healthcare organizations getting better results?

Continue Reading...

COVID-19: Insurers Exempt from Covering Workplace Testing

Must Cover “Medically Appropriate” Tests Only

Continue Reading...

Avoid the Top 3 RCM Pitfalls with Automation

Using different systems for RCM may be holding back productivity and hitting your bottom line.

Continue Reading...